Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease

Boyer-Diaz, Z; Aristu-Zabalza, P; Andres-Rozas, M; Robert, C; Ortega-Ribera, M; Fernandez-Iglesias, A; Broqua, P; Junien, JL; Wettstein, G; Bosch, J; Gracia-Sancho, J

Gracia-Sancho, J (corresponding author), IDIBAPS, Liver Vasc Biol Res Grp, Rossello 149, Barcelona 08036, Spain.

JOURNAL OF HEPATOLOGY, 2021; 74 (5): 1188